ALUR Stock Summary and Trading Ideas (Allurion Technologies | NYSE:ALUR)

Allurion Technologies Inc is a medical device company that focuses on creating a best-in-class weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.

Allurion Technologies trades on the NYSE stock market under the symbol ALUR.

As of February 7, 2025, ALUR stock price declined to $6.04 with 180,430 million shares trading.

ALUR has a market cap of $28.95 million. This is considered a Sub-Micro Cap stock.

Last quarter Allurion Technologies reported $5 million in Revenue and -$3.50 earnings per share. This fell short of revenue expectation by $-3 million and exceeded earnings estimates by $1.00.

The top ETF exchange traded funds that ALUR belongs to (by Net Assets): VTI, VXF, IWC.

ALUR has underperformed the market in the last year with a price return of -91.9% while the SPY ETF gained +22.0%. ALUR has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -65.7% and -30.5%, respectively, while the SPY returned +1.2% and -1.2%, respectively.

ALUR support price is $5.48 and resistance is $7.52 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ALUR shares will trade within this expected range on the day.